Encompass Health $EHC

Health Care · NYSE

Russell 1000 Alabama
$133.65
+1.37 (+1.04%)
As of Nov 20, 2026, 4:05 PM EST · cached
Price history
Loading chart…
Today's analyst average Analyst average over timeIndividual analyst targets Analyst history starts Oct 30, 2026, the first target we tracked for EHC.

Encompass Health (EHC) is trading up at $133.65 (+1.04%) on NYSE, as of the latest quote. It is a Russell 1000 constituent in the Health Care sector.

Analyst price targets on EHC

One firm's current price target on Encompass Health: $155 — 16% above the current $134. Each is tracked to its date and scored the same way a member's call is.

1 target, newest first. Open a row for its source and scoring.

DateOct 30, 2026 FirmRaymond James RatingStrong Buy · raises Targetat $131 · $155 +18% Horizonby Oct 2027 StatusOpen

Entry price $131, the close nearest Oct 30, 2026, when the target was reported; the target is +18% from it.

Horizon No horizon stated, so it is tracked over the 12-month default, to Oct 2027.

Scoring Open: judged on the close on Oct 30, 2027.

Source Raymond James raises Encompass Health stock price target on strong results Investing.com · Oct 30, 2026 · opens the publisher's site
to $155 from $150 while maintaining a Strong Buy rating on the shares.

Targets published by research firms, extracted from the news, checked against independent reporting, and linked to their source. Where a firm did not state a horizon the target is tracked as 12 months, the industry convention; the rows where the firm set its own horizon are marked. “At” is the closing price nearest the day the target was reported, the price we score it from; it is not an earlier target. Reported here as facts about what was published — not recommendations from Dalsna Finance, and no firm listed is affiliated with this site.

Encompass Health revenue & net income history (FY2016–FY2025)

RevenueNet incomeNet margin (right axis, %)
$5.94B$2.97B$0FY2016 revenue: $3.64BFY2016 net income: $247.6M · Net margin 6.8%'16FY2017 revenue: $3.91BFY2017 net income: $271.1M · Net margin 6.9%'17FY2018 revenue: $4.28BFY2018 net income: $292.3M · Net margin 6.8%'18FY2019 revenue: $4.61BFY2019 net income: $358.7M · Net margin 7.8%'19FY2020 revenue: $3.57BFY2020 net income: $284.2M · Net margin 8.0%'20FY2021 revenue: $4.01BFY2021 net income: $412.2M · Net margin 10.3%'21FY2022 revenue: $4.35BFY2022 net income: $271.0M · Net margin 6.2%'22FY2023 revenue: $4.80BFY2023 net income: $352.0M · Net margin 7.3%'23FY2024 revenue: $5.37BFY2024 net income: $455.7M · Net margin 8.5%'24FY2025 revenue: $5.94BFY2025 net income: $566.2M · Net margin 9.5%'250%5%10%15%FY2016 net margin: 6.8%FY2017 net margin: 6.9%FY2018 net margin: 6.8%FY2019 net margin: 7.8%FY2020 net margin: 8.0%FY2021 net margin: 10.3%FY2022 net margin: 6.2%FY2023 net margin: 7.3%FY2024 net margin: 8.5%FY2025 net margin: 9.5%
Encompass Health annual financial statements
FY2016Dec 2016FY2017Dec 2017FY2018Dec 2018FY2019Dec 2019FY2020Dec 2020FY2021Dec 2021FY2022Dec 2022FY2023Dec 2023FY2024Dec 2024FY2025Dec 2025
Income statement
Revenue$3.64B$3.91B$4.28B$4.61B$3.57B$4.01B$4.35B$4.80B$5.37B$5.94B
Growth (year over year)—+7.4%+9.3%+7.7%−22.6%+12.6%+8.3%+10.4%+11.9%+10.5%
Operating income$588.1M$578.3M$555.2M$612.1M$563.9M$559.6M$539.5M———
Operating margin16.1%14.8%13.0%13.3%15.8%13.9%12.4%———
Net income$247.6M$271.1M$292.3M$358.7M$284.2M$412.2M$271.0M$352.0M$455.7M$566.2M
Net margin6.8%6.9%6.8%7.8%8.0%10.3%6.2%7.3%8.5%9.5%
EPS (diluted)$2.59$2.84$2.93$3.61$2.85$4.11$2.70$3.47$4.46$5.54
Balance sheet
Cash and equivalents$40.5M$54.4M$69.2M$60.0M$185.6M$49.4M$21.8M$69.1M$85.4M$72.2M
Total assets$4.68B$4.86B$5.17B$6.08B$6.45B$6.86B$5.64B$6.10B$6.53B$7.09B
Total liabilities$3.61B$3.25B$3.36B$4.15B$4.44B$4.47B$3.77B$3.81B$3.69B$3.81B
Long-term debt$2.98B$2.55B$2.48B$3.02B$3.25B$3.24B$2.74B$2.69B$2.36B$2.45B
Shareholders' equity$735.9M$1.15B$1.28B$1.35B$1.59B$1.91B$1.31B$1.65B$2.07B$2.44B
Cash flow
Operating cash flow$640.2M$658.3M$762.4M$635.3M$704.7M$715.8M$705.8M$850.8M$1.00B$1.18B
Capital expenditure$177.7M$225.8M$254.5M$372.4M$392.8M$524.6M$564.8M$583.1M$642.5M$736.4M
Free cash flow$462.5M$432.5M$507.9M$262.9M$311.9M$191.2M$141.0M$267.7M$360.3M$439.2M
Dividends paid$83.8M$91.5M$100.8M$108.7M$111.8M$112.2M$99.0M$60.4M$62.8M$71.1M
Share buybacks$65.6M$38.1M$0$45.9M$6.10M$0$0$0$31.1M$158.0M

From Encompass Health's 10-K and 10-Q filings with the SEC; its fiscal year ends in December. Each period shows the latest figure the company has reported for it, including restatements. Net margin is our own calculation from those reported figures (net income ÷ revenue); it is left blank where revenue is zero or missing. † Quarter derived from the company's year-to-date or full-year totals. Filings on SEC EDGAR →

Encompass Health in the news

Oct 30, 2026 Investing.com Raymond James raises Encompass Health stock price target on strong results Target

About Encompass Health

Encompass Health Corporation, formerly Amcare and HealthSouth, based in Birmingham, Alabama, is the United States's largest provider of inpatient rehabilitative services, offering facility-based care through its network of 173 inpatient rehabilitation hospitals located in 39 states and Puerto Rico. Encompass Health's hospitals focus on providing rehabilitative treatment and care to patients who are recovering from stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions and amputations. The company operated a home health and hospice business that was spun off as Enhabit in 2022.

Source: Wikipedia — Encompass Health

Headquarters
Birmingham, Alabama From SEC filings, Oct 2026

More Health Care stocks

Browse all companies →